Business · 09/03/2026Updated: 10/16/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for Oncologic Drugs
Summary
The FDA is hosting a public meeting of the Oncologic Drugs Advisory Committee to provide advice on new drug applications for Camizestrant and Truqap, and is seeking public comments on the process.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →